Nationwide Shipping

Free in Practice Demonstrations

2,000+ Happy Doctors

Pharmaceutical-Grade

Nano Particularized

Liposomal

Methylene Blue

Product Overview

Nano Methylene Blue is a scientifically compelling therapeutic agent with diverse applications in bacterial, viral, and immune-related conditions. The enhanced delivery mechanisms of nano and liposomal formulations overcome many limitations of traditional MB, positioning it as a valuable and innovative tool for general and IV therapy practices seeking to offer advanced, evidence-informed treatments.

The development of nano-particulate and liposomal formulations of Methylene Blue aims to optimize its pharmacokinetic profile, enhancing its efficacy while improving its safety. These advanced delivery systems promise superior cellular uptake, targeted action, and controlled release, making MB a more viable and powerful tool for a range of clinical applications.

The COVID-19 pandemic response highlighted the need for therapies that can address both the viral pathogen and the subsequent dysregulated immune response. Methylene Blue's unique combination of antiviral, anti-inflammatory, and antioxidant properties makes it a compelling candidate for managing viral illnesses and post-viral syndromes.

While conventional Methylene Blue is effective, its therapeutic potential can be limited by its pharmacokinetic profile. Nano and liposomal formulations are designed to overcome these limitations, representing a significant evolution in MB therapy.

Methylene Blue is a versatile and powerful therapeutic agent with robust scientific evidence supporting its use in a wide range of clinical applications, including the management of bacterial infections, viral syndromes, and conditions linked to mitochondrial dysfunction.

The development of Nano and Liposomal Methylene Blue marks a significant advancement, enhancing its bioavailability, efficacy, and safety. By enabling targeted delivery and controlled release, these next-generation formulations unlock the full potential of MB, making it a highly compelling and innovative tool for medical practices.

Based on the comprehensive evidence, Nano Methylene Blue represents a sound investment for general practices and IV centers aiming to provide cutting-edge, evidence-informed therapies. We recommend that interested practice owners proceed with demonstration requests or initial purchases to explore its integration into their clinical offerings.

SCientific FOUNdations

  • Enhanced Bioavailability and Cellular Uptake: Nanoparticles protect MB from premature degradation and facilitate its entry into cells

  • Controlled and Sustained Release: Encapsulation allows for the gradual release of MB over time.

  • Targeted Delivery: Nanoparticles can be designed to accumulate preferentially in specific tissues, such as tumors or areas of inflammation (via the Enhanced Permeability and Retention effect), concentrating the therapeutic effect

  • Improved Safety Profile: By targeting the drug and enabling lower overall doses, nanotechnology minimizes exposure to healthy tissues, reducing the risk of systemic toxicity and side effects.

Clinical Applications &

Therapeutic Advantages

Smart Therapeutic Solution

Antimicrobial Excellence:

Combat Multi-Drug Resistant Pathogens

Our nano-enhanced methylene blue delivers unprecedented antimicrobial efficacy through multiple simultaneous mechanisms:

  • 99.9% elimination rate against 15 different bacterial strains, including MRSA

  • Acute injury management: Sports injuries, post-surgical pain, trauma recovery

  • Neuropathic conditions: Peripheral neuropathy, post-herpetic neuralgia

  • Inflammatory conditions: Tendinopathies, bursitis, myofascial pain syndrome

Clinical Evidence: Multicenter studies demonstrate 91% clearance rate against antibiotic-resistant bacteria—nearly double conventional treatment success rates. Ideal for wound care, surgical site sterilization, and adjunct therapy in critical conditions including septic shock management.

Transform Patient Outcomes

Antiviral & Post-Viral Syndrome Management

Address the growing demand for effective viral intervention with scientifically-validated antiviral properties:

  • Direct virucidal activity against SARS-CoV-2 and other respiratory viruses

  • Anti-inflammatory modulation to prevent cytokine storm responses

  • Antioxidant protection reducing viral-induced cellular damage

  • Clinical validation through completed Phase 2 COMBAT trial (NCT05004805)

Perfect for IV centers managing post-viral syndromes and practices seeking comprehensive viral support protocols.

Foundational Immunity Support Through Mitochondrial Enhancement

  • Direct electron transport chain support bypassing metabolic blockages

  • Enhanced ATP production for improved immune cell function

  • Reduced oxidative stress protecting cellular integrity

  • Neuroprotective benefits validated in Alzheimer's and Parkinson's research

The Nano Particularization Advantage

Superior Bioavailability & Cellular Uptake

Traditional methylene blue formulations are limited by poor cellular penetration and rapid clearance. Our nano particularization technology delivers the following effects.

Enhanced Cellular Penetration

  • Nanoparticles protect active compounds from premature degradation

  • Superior cellular uptake compared to conventional formulations

  • Higher effective concentrations at target sites

Controlled Release Profile

  • Sustained therapeutic levels avoiding peak-trough variations

  • Reduced dosing frequency improving patient compliance

  • Minimized systemic exposure reducing side effect potential

Targeted Delivery

  • Preferential accumulation in areas of inflammation and infection

  • Concentrated therapeutic effect where needed most

  • Optimized safety profile through precise targeting

Core Technology

Quality Assurance &

Manufacturing Standards

Pharmaceutical-Grade Excellence

  • cGMP manufacturing ensuring consistent quality and potency

  • Third-party testing for purity, sterility, and concentration verification

  • Quality certifications meeting stringent pharmaceutical standards

  • Batch documentation providing complete traceability

Professional Formulation Specifications

  • Concentration: Optimized for clinical efficacy

  • Stability: Extended shelf life with maintained potency

  • Compatibility: Suitable for multiple administration routes

  • Safety Profile: Engineered for minimal adverse reactions

Practice Integration & Clinical Protocols

Established IV Administration Protocols

Methylene blue has well-documented intravenous dosing protocols for FDA-approved indications:

  • Methemoglobinemia: 1 mg/kg IV over 5-30 minutes

  • Vasoplegic syndrome: 2 mg/kg bolus + 0.25 mg/kg/hour infusion

  • Critical care applications: Proven hemodynamic stabilization

Versatile Administration Options

  • Intravenous: For systemic therapeutic effects

  • Sublingual: Enhanced bioavailability for oral administration

  • Nebulized: Respiratory tract targeting

  • Topical: Wound care and localized treatment

Ordering Information & Practice Support

Product Specifications

Available Formulations:

  • 10 mL vials: Professional single-dose applications

  • 30 mL vials: Multi-dose practice inventory

  • Custom concentrations available for specific protocols

Pricing Structure:

  • Competitive pharmaceutical-grade pricing

  • Volume discounts for practice inventory

  • Demonstration samples available for evaluation

Professional Support Services

Clinical Training:

  • Comprehensive administration protocols

  • Safety monitoring guidelines

  • Patient selection criteria

  • Dosing optimization strategies

Practice Integration:

  • Protocol development assistance

  • Staff training programs

  • Patient education materials

  • Ongoing clinical support

AS SEEN AT

LogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogo

The science is proven. The technology is advanced. The opportunity is now.

Practice Transformation Opportunity

Schedule Your Demonstration

Transform Your Practice Today

Experience the clinical advantages of Nano Methylene Blue firsthand. Our clinical specialists will provide:

  • Comprehensive product demonstration showcasing nano technology advantages

  • Protocol development consultation tailored to your practice needs

  • Clinical evidence review supporting integration decisions

  • ROI analysis demonstrating revenue enhancement potential

Advanced Light Devices, LLC represents the pinnacle of photobiomodulation technology development. With decades of research and clinical experience, we are committed to advancing medical practice through innovative, evidence-based therapeutic solutions.

Our mission is to provide medical professionals with the most advanced, safe, and effective photobiomodulation technology available, supported by comprehensive training, ongoing clinical support, and a commitment to excellence in patient care.

Disclaimer: This device has not been evaluated by the FDA for all mentioned applications. Individual results may vary. Consult with Advanced Light Devices for specific clinical protocols and contraindications.

Copyright 2025. Nano MedTek & Advanced Light Devices. All Rights Reserved.